Proteome Sciences (PRM)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 4.21p
   
  • Change Today:
      0.000p
  • 52 Week High: 8.50p
  • 52 Week Low: 2.97p
  • Currency: UK Pounds
  • Shares Issued: 295.18m
  • Volume: 119
  • Market Cap: £12.43m
  • RiskGrade: 353

Proteome slides after warning on revenues

Date: Wednesday 12 Nov 2014

LONDON (ShareCast) - Shares in Proteome fell sharply on Wednesday after the group warned its revenue for the current year will be lower than market expectations and "somewhat" lower than the revenues achieved in 2013.
The protein biomarker group explained that it had seen a continuation of the previously flagged delay to the start date of several contracts, the revenue for which is now expected to be reflected in 2015.

It did, however, add that this revenue would be supported by strong underlying growth in both biomarker services and TMT.

Proteome also said that commercial discussions to out-license the diagnostic applications for MCI/AD detection had begun with a number of interested parties who have signed confidentiality agreements.

"The CK1d dossier has been completed and the process to progress the outlicensing programme with pharmaceutical companies has started," the company said.

"Both are high value applications in Alzheimer's disease and should provide a combination of signature fees, milestone payments and royalties. We expect to have fuller visibility of these in 2015."

The company's cash position remained "healthy", with cash at bank at the end of 31 October totalling £1.72m.

"We are seeing further underlying growth in our pipeline and core technologies and remain confident that this should be reflected in revenues in 2015 and beyond," it added.

Shares had fallen 14.85% to 29.17p by 11:54.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

PRM Market Data

Currency UK Pounds
Share Price 4.21p
Change Today 0.000p
% Change 0.00 %
52 Week High 8.50p
52 Week Low 2.97p
Volume 119
Shares Issued 295.18m
Market Cap £12.43m
RiskGrade 353

PRM Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
15.79% below the market average15.79% below the market average15.79% below the market average15.79% below the market average15.79% below the market average
56.86% above the sector average56.86% above the sector average56.86% above the sector average56.86% above the sector average56.86% above the sector average
Price Trend
30.08% below the market average30.08% below the market average30.08% below the market average30.08% below the market average30.08% below the market average
28.30% above the sector average28.30% above the sector average28.30% above the sector average28.30% above the sector average28.30% above the sector average
Income Not Available
Growth
46.00% above the market average46.00% above the market average46.00% above the market average46.00% above the market average46.00% above the market average
71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average

PRM Dividends

No dividends found

Trades for 14-Jun-2024

Time Volume / Share Price
09:56 119 @ 4.19p

PRM Key Personnel

CFO Abdelghani Omari

Top of Page